Stock SCD ZENTIVA S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zentiva S.A.

Equities

SCD

ROSCDBACNOR8

Pharmaceuticals

End-of-day quote Bucharest S.E.
Other stock markets
 06:00:00 2024-05-19 pm EDT 		5-day change 1st Jan Change
3.22 RON -1.23% Intraday chart for Zentiva S.A. -1.23% +10.27%
Apr. 01 Biocon Limited, Through Zentiva, Receives Approval from, U.K., for its Complex Formulation Liraglutide (gSaxenda®) in 6mg/ml Solution CI
Feb. 29 Zentiva S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Zentiva SA is a Romania-based company engaged in the pharmaceutical industry. The Company is primarily engaged in the production and commercialization of pharmaceutical preparations. The Company’s portfolio includes approximately 280 products and drugs for cardiovascular, nervous and digestive systems; pain treatment, and urological and anti-inflammatory diseases, among others. Additionally, the Company is active in the production of dietary supplements and vitamins. It has production sites in Czech Republic, Slovakia, Romania and Turkey. As of December 31, 2011, Venoma Holdings Limited held a 50.98% stake in Zentiva SA. The Company had one wholly owned subsidiary, Pallady Business Park SRL, as of December 31, 2011.

Number of employees: 952

Sales per Business

RON in Million2022Weight2023Weight Delta
Medicines - Finished Goods
77.8 %
639 84.1 % 742 77.8 % +16.19%
Medicines - Merchandise
21.5 %
112 14.8 % 205 21.5 % +83.02%
Services
6.2 %
55 7.2 % 60 6.2 % +8.45%
Claw Back Tax Expense
-5.6 %
-48 -6.4 % -53 -5.6 % +9.68%
Medicines - Residual Products
0.0 %
3 0.3 % 0 0.0 % -96.60%

Sales per region

RON in Million2022Weight2023Weight Delta
Romania
100.0 %
760 100.0 % 954 100.0 % +25.54%

Managers

Managers TitleAgeSince
Simona Cocos CEO
 Chief Executive Officer 57 09-09-30
Daniel Nitulescu DFI
 Director of Finance/CFO - -
Margareta Tanase BRD
 Director/Board Member 64 99-12-31
Tereza Ber LAW
 General Counsel - -
Ines Windisch HRO
 Human Resources Officer - -

Members of the board

Members of the board TitleAgeSince
Simona Cocos CEO
 Chief Executive Officer 57 09-09-30
Margareta Tanase BRD
 Director/Board Member 64 99-12-31
Francois Noel Merchand BRD
 Director/Board Member 53 17-02-19
Kenneth Lynard BRD
 Director/Board Member 56 19-09-30
Alin Briciu BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 697,017,040 28,238,939 ( 4.051 %) 0 4.051 %

Shareholders

NameEquities%Valuation
Eurobank Asset Management M.F.M.C. SA
0.0139 %
97,000 0.0139 % 67 945 lei
Evergent Investments SA (Investment Management)
0.0128 %
89,500 0.0128 % 62 691 lei

Company contact information

Zentiva SA

50, Theodor Pallady Boulevard Sector 3

032266, Bucharest

+40 21 304 7200

http://www.zentiva.ro
address Zentiva S.A.(SCD)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sector Generic Pharmaceuticals

1st Jan change Capi.
ZENTIVA S.A. Stock Zentiva S.A.
+10.27% 497M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+21.63% 44.12B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+22.99% 22.71B
SANDOZ GROUP AG Stock Sandoz Group AG
+18.22% 15.15B
CIPLA LIMITED Stock Cipla Limited
+12.66% 13.61B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+60.18% 13.34B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.35% 6.84B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+15.65% 5.63B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SCD Stock
  4. Company Zentiva S.A.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW